Laidlaw & Company is sole placement agent.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NCNA:
- NuCana’s Mixed Clinical Results and Financial Caution Lead to Hold Rating
- NuCana Reports 2024 Financial Results and Advances Cancer Treatment Programs
- NuCana reports Q4 loss per share GBP (0.01) vs GBP (.14)
- NuCana Reports Q4 EPS GBP (1) vs. GBP (14)
- NuCana Calls for Shareholder Vote on Key Resolutions